Racial differences in genome-wide methylation profiling and gene expression in breast tissues from healthy women

References

• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA 2015; 65:5-29; PMID:25559415
   PubMed Web of Science ®Google Scholar
• Ambrosone CB, Young AC, Sucheston LE, Wang D, Yan L, Liu S, Tang L, Hu Q, Freudenheim JL, Shields PG, et al. Genome-wide methylation patterns provide insight into differences in breast tumor biology between American women of African and European ancestry. Oncotarget 2014; 5:237-48; PMID:24368439; http://dx.doi.org/10.18632/oncotarget.1599
   PubMed Web of Science ®Google Scholar
• Wang S, Dorsey TH, Terunuma A, Kittles RA, Ambs S, Kwabi-Addo B. Relationship between tumor DNA methylation status and patient characteristics in African-American and European-American women with breast cancer. PloS One 2012; 7:e37928; PMID:22701537; http://dx.doi.org/10.1371/journal.pone.0037928
   PubMed Web of Science ®Google Scholar
• Das PM, Singal R. DNA methylation and cancer. J Clin Oncol 2004; 22:4632-42; PMID:15542813; http://dx.doi.org/10.1200/JCO.2004.07.151
   PubMed Web of Science ®Google Scholar
• Christensen BC, Kelsey KT, Zheng S, Houseman EA, Marsit CJ, Wrensch MR, Wiemels JL, Nelson HH, Karagas MR, Kushi LH, et al. Breast cancer DNA methylation profiles are associated with tumor size and alcohol and folate intake. PLoS Genet 2010; 6:e1001043; PMID:20686660; http://dx.doi.org/10.1371/journal.pgen.1001043
   PubMed Web of Science ®Google Scholar
• Johnson KC, Koestler DC, Cheng C, Christensen BC. Age-related DNA methylation in normal breast tissue and its relationship with invasive breast tumor methylation. Epigenetics 2014; 9:268-75; http://dx.doi.org/10.4161/epi.27015
   PubMed Web of Science ®Google Scholar
• Tao MH, Marian C, Shields PG, Nie J, McCann SE, Millen A, Ambrosone C, Hutson A, Edge SB, Krishnan SS, et al. Alcohol consumption in relation to aberrant DNA methylation in breast tumors. Alcohol 2011; 45:689-99; PMID:21168302; http://dx.doi.org/10.1016/j.alcohol.2010.11.006
   PubMed Web of Science ®Google Scholar
• Tao MH, Marian C, Nie J, Ambrosone C, Krishnan SS, Edge SB, Trevisan M, Shields PG, Freudenheim JL. Body mass and DNA promoter methylation in breast tumors in the Western New York Exposures and Breast Cancer Study. Am J Clin Nutri 2011; 94:831-8; PMID:21775555; http://dx.doi.org/10.3945/ajcn.110.009365
   PubMed Web of Science ®Google Scholar
• Conway K, Edmiston SN, Tse CK, Bryant C, Kuan PF, Hair BY, Parrish EA, May R, Swift-Scanlan T. Racial variation in breast tumor promoter methylation in the Carolina Breast Cancer Study. Cancer Epidemiology Biomarkers Prevention 2015; 24:921-30; http://dx.doi.org/10.1158/1055-9965.EPI-14-1228
   PubMed Web of Science ®Google Scholar
• Dumitrescu RG, Marian C, Krishnan SS, Spear SL, Kallakury BV, Perry DJ, Convit JR, Seillier-Moiseiwitsch F, Yang Y, Freudenheim JL, et al. Familial and racial determinants of tumour suppressor genes promoter hypermethylation in breast tissues from healthy women. J Cell Mol Med 2010; 14:1468-75; PMID:19799643; http://dx.doi.org/10.1111/j.1582-4934.2009.00924.x
   PubMed Web of Science ®Google Scholar
• Llanos AA, Dumitrescu RG, Brasky TM, Liu Z, Mason JB, Marian C, Makambi KH, Spear SL, Kallakury BV, Freudenheim JL, et al. Relationships among folate, alcohol consumption, gene variants in one-carbon metabolism and p16INK4a methylation and expression in healthy breast tissues. Carcinogenesis 2015; 36:60-7; PMID:25344837; http://dx.doi.org/10.1093/carcin/bgu219
   PubMed Web of Science ®Google Scholar
• Llanos AA, Marian C, Brasky TM, Dumitrescu RG, Liu Z, Mason JB, Makambi KH, Spear SL, Kallakury BV, Freudenheim JL, et al. Associations between genetic variation in one-carbon metabolism and LINE-1 DNA methylation in histologically normal breast tissues. Epigenetics 2015; 10:727-35; http://dx.doi.org/10.1080/15592294.2015.1062205
   PubMed Web of Science ®Google Scholar
• Zhang FF, Cardarelli R, Carroll J, Fulda KG, Kaur M, Gonzalez K, Vishwanatha JK, Santella RM, Morabia A. Significant differences in global genomic DNA methylation by gender and race/ethnicity in peripheral blood. Epigenetics 2011; 6:623-9; http://dx.doi.org/10.4161/epi.6.5.15335
   PubMed Web of Science ®Google Scholar
• Terry MB, Ferris JS, Pilsner R, Flom JD, Tehranifar P, Santella RM, Gamble MV, Susser E. Genomic DNA methylation among women in a multiethnic New York City birth cohort. Cancer Epidemiology Biomarkers Prevention 2008; 17:2306-10; http://dx.doi.org/10.1158/1055-9965.EPI-08-0312
   PubMed Web of Science ®Google Scholar
• Adkins RM, Krushkal J, Tylavsky FA, Thomas F. Racial differences in gene-specific DNA methylation levels are present at birth. Birth Defects Res Clin Mol Teratology 2011; 91:728-36; PMID:21308978; http://dx.doi.org/10.1002/bdra.20770
   PubMed Web of Science ®Google Scholar
• Sotiriou C, Pusztai L. Gene-expression signatures in breast cancer. N Engl J Med 2009; 360:790-800; PMID:19228622; http://dx.doi.org/10.1056/NEJMra0801289
   PubMed Web of Science ®Google Scholar
• Pirone JR, D'Arcy M, Stewart DA, Hines WC, Johnson M, Gould MN, Yaswen P, Jerry DJ, Smith Schneider S, Troester MA. Age-associated gene expression in normal breast tissue mirrors qualitative age-at-incidence patterns for breast cancer. Cancer Epidemiology Biomarkers Prevention 2012; 21:1735-44; http://dx.doi.org/10.1158/1055-9965.EPI-12-0451
   PubMed Web of Science ®Google Scholar
• Sun X, Casbas-Hernandez P, Bigelow C, Makowski L, Joseph Jerry D, Smith Schneider S, Troester MA. Normal breast tissue of obese women is enriched for macrophage markers and macrophage-associated gene expression. Breast Cancer Res Treatment 2012; 131:1003-12; PMID:22002519; http://dx.doi.org/10.1007/s10549-011-1789-3
   PubMed Web of Science ®Google Scholar
• Rotunno M, Sun X, Figueroa J, Sherman ME, Garcia-Closas M, Meltzer P, Williams T, Schneider SS, Jerry DJ, Yang XR, et al. Parity-related molecular signatures and breast cancer subtypes by estrogen receptor status. Breast cancer Res 2014; 16:R74; PMID:25005139; http://dx.doi.org/10.1186/bcr3689
   PubMed Web of Science ®Google Scholar
• Sun X, Gierach GL, Sandhu R, Williams T, Midkiff BR, Lissowska J, Wesolowska E, Boyd NF, Johnson NB, Figueroa JD, et al. Relationship of mammographic density and gene expression: analysis of normal breast tissue surrounding breast cancer. Clin Cancer Res 2013; 19:4972-82; PMID:23918601; http://dx.doi.org/10.1158/1078-0432.CCR-13-0029
   PubMed Web of Science ®Google Scholar
• Llanos AA, Brasky TM, Dumitrescu RG, Marian C, Makambi KH, Kallakury BV, Spear SL, Perry DJ, Convit RJ, Platek ME, et al. Plasma IGF-1 and IGFBP-3 may be imprecise surrogates for breast concentrations: an analysis of healthy women. Breast Cancer Res Treatment 2013; 138:571-9; PMID:23456194; http://dx.doi.org/10.1007/s10549-013-2452-y
   PubMed Web of Science ®Google Scholar
• Maksimovic J, Gordon L, Oshlack A. SWAN: Subset-quantile within array normalization for illumina infinium HumanMethylation450 BeadChips. Genome Biol 2012; 13:R44; PMID:22703947; http://dx.doi.org/10.1186/gb-2012-13-6-r44
   PubMed Web of Science ®Google Scholar
• Price ME, Cotton AM, Lam LL, Farre P, Emberly E, Brown CJ, Robinson WP, Kobor MS. Additional annotation enhances potential for biologically-relevant analysis of the Illumina Infinium HumanMethylation450 BeadChip array. Epigenetics Chromatin 2013; 6:4; PMID:23452981; http://dx.doi.org/10.1186/1756-8935-6-4
   PubMed Web of Science ®Google Scholar
• Chen YA, Lemire M, Choufani S, Butcher DT, Grafodatskaya D, Zanke BW, Gallinger S, Hudson TJ, Weksberg R. Discovery of cross-reactive probes and polymorphic CpGs in the Illumina Infinium HumanMethylation450 microarray. Epigenetics 2013; 8:203-9; http://dx.doi.org/10.4161/epi.23470
   PubMed Web of Science ®Google Scholar
• Du P, Zhang X, Huang CC, Jafari N, Kibbe WA, Hou L, Lin SM. Comparison of Beta-value and M-value methods for quantifying methylation levels by microarray analysis. BMC Bioinformatics 2010; 11:587; PMID:21118553; http://dx.doi.org/10.1186/1471-2105-11-587
   PubMed Web of Science ®Google Scholar
• Quackenbush J. Computational analysis of microarray data. Nat Rev Genetics 2001; 2:418-27; PMID:11389458; http://dx.doi.org/10.1038/35076576
   PubMed Web of Science ®Google Scholar
• Williams HAaLJ. Principal component analysis. Wiley Interdisciplinary Rev 2010; 2:433-59; http://dx.doi.org/10.1002/wics.101
   Google Scholar
• Bibikova M, Barnes B, Tsan C, Ho V, Klotzle B, Le JM, Delano D, Zhang L, Schroth GP, Gunderson KL, et al. High density DNA methylation array with single CpG site resolution. Genomics 2011; 98:288-95; PMID:21839163; http://dx.doi.org/10.1016/j.ygeno.2011.07.007
   PubMed Web of Science ®Google Scholar
• Bock C, Walter J, Paulsen M, Lengauer T. CpG island mapping by epigenome prediction. PLoS Computational Biol 2007; 3:e110; PMID:17559301; http://dx.doi.org/10.1371/journal.pcbi.0030110
   PubMed Web of Science ®Google Scholar
• Lorincz MC, Dickerson DR, Schmitt M, Groudine M. Intragenic DNA methylation alters chromatin structure and elongation efficiency in mammalian cells. Nat Struct Mol Biol 2004; 11:1068-75; PMID:15467727; http://dx.doi.org/10.1038/nsmb840
   PubMed Web of Science ®Google Scholar
• Kornblihtt AR. Chromatin, transcript elongation and alternative splicing. Nat Struct Mol Biol 2006; 13:5-7; PMID:16395314; http://dx.doi.org/10.1038/nsmb0106-5
   PubMed Web of Science ®Google Scholar
• Suzuki MM, Bird A. DNA methylation landscapes: provocative insights from epigenomics. Nat Rev Genetics 2008; 9:465-76; PMID:18463664; http://dx.doi.org/10.1038/nrg2341
   PubMed Web of Science ®Google Scholar
• Jones PA. Functions of DNA methylation: islands, start sites, gene bodies and beyond. Nat Rev Genetics 2012; 13:484-92; PMID:22641018; http://dx.doi.org/10.1038/nrg3230
   PubMed Web of Science ®Google Scholar
• Wagner JR, Busche S, Ge B, Kwan T, Pastinen T, Blanchette M. The relationship between DNA methylation, genetic and expression inter-individual variation in untransformed human fibroblasts. Genome Biol 2014; 15:R37; PMID:24555846; http://dx.doi.org/10.1186/gb-2014-15-2-r37
   PubMed Web of Science ®Google Scholar
• Fleischer T, Frigessi A, Johnson KC, Edvardsen H, Touleimat N, Klajic J, Riis ML, Haakensen VD, Warnberg F, Naume B, et al. Genome-wide DNA methylation profiles in progression to in situ and invasive carcinoma of the breast with impact on gene transcription and prognosis. Genome Biol 2014; 15:435; PMID:25146004
   PubMed Web of Science ®Google Scholar
• Lucia Radici MB, Rita Crinelli, Mauro Magnani Ubiquitin C gene: Structure, function, and transcriptional regulation Adv Biosci Biotechnol 2013; 4:1057-62; http://dx.doi.org/10.4236/abb.2013.412141
   Google Scholar
• Ohta T, Fukuda M. Ubiquitin and breast cancer. Oncogene 2004; 23:2079-88; PMID:15021895; http://dx.doi.org/10.1038/sj.onc.1207371
   PubMed Web of Science ®Google Scholar
• Xiang Y, Zhang J, Huang K. Mining the tissue-tissue gene co-expression network for tumor microenvironment study and biomarker prediction. BMC Genomics 2013; 14 Suppl 5:S4; PMID:24564578; http://dx.doi.org/10.1186/1471-2164-14-S5-S4
   PubMed Web of Science ®Google Scholar
• Howlin J, Rosenkvist J, Andersson T. TNK2 preserves epidermal growth factor receptor expression on the cell surface and enhances migration and invasion of human breast cancer cells. Breast Cancer Res 2008; 10:R36; PMID:18435854; http://dx.doi.org/10.1186/bcr2087
   PubMed Web of Science ®Google Scholar
• Mahajan K, Mahajan NP. ACK1/TNK2 tyrosine kinase: molecular signaling and evolving role in cancers. Oncogene 2014; 34(32):4162-7
   PubMed Web of Science ®Google Scholar
• Sellar GC, Watt KP, Rabiasz GJ, Stronach EA, Li L, Miller EP, Massie CE, Miller J, Contreras-Moreira B, Scott D, et al. OPCML at 11q25 is epigenetically inactivated and has tumor-suppressor function in epithelial ovarian cancer. Nat Genetics 2003; 34:337-43; PMID:12819783; http://dx.doi.org/10.1038/ng1183
   PubMed Web of Science ®Google Scholar
• Cui Y, Ying Y, van Hasselt A, Ng KM, Yu J, Zhang Q, Jin J, Liu D, Rhim JS, Rha SY, et al. OPCML is a broad tumor suppressor for multiple carcinomas and lymphomas with frequently epigenetic inactivation. PloS One 2008; 3:e2990; PMID:18714356; http://dx.doi.org/10.1371/journal.pone.0002990
   PubMed Web of Science ®Google Scholar
• D'Orazi G, Rinaldo C, Soddu S. Updates on HIPK2: a resourceful oncosuppressor for clearing cancer. J Exp Clin Cancer Res 2012; 31:63; http://dx.doi.org/10.1186/1756-9966-31-63
   PubMed Web of Science ®Google Scholar
• Lian CG, Xu Y, Ceol C, Wu F, Larson A, Dresser K, Xu W, Tan L, Hu Y, Zhan Q, et al. Loss of 5-hydroxymethylcytosine is an epigenetic hallmark of melanoma. Cell 2012; 150:1135-46; PMID:22980977; http://dx.doi.org/10.1016/j.cell.2012.07.033
   PubMed Web of Science ®Google Scholar